期刊文献+

腺病毒介导反义CⅡTA基因对实验性自身免疫性心肌炎的治疗 被引量:2

Adenovirus-mediated gene transfer of antisense CⅡTA ameliorates ongoing experimental autoimmune myocarditis
原文传递
导出
摘要 目的 研究反义CⅡTA基因对心肌肌凝蛋白诱导的实验性自身免疫性心肌炎 (experi mentalautoimmunemyocarditis,EAM)的治疗作用。方法 以携带反义CⅡTA基因的腺病毒载体对肌凝蛋白免疫后的小鼠进行静脉注射 ,同时设立空载病毒组与单纯免疫组作为对照 ,以多种手段观察反义CⅡTA基因对EAM的治疗效果。结果 治疗组与两对照组相比 ,心肌病理损伤程度减轻 ;血浆抗心肌肌凝蛋白抗体滴度及cTnⅠ浓度明显下降 (P <0 .0 5 ) ,流式细胞术检测外周血与脾脏T细胞I Ad表达量明显下降 (P <0 .0 5 )。结论 反义CⅡTA基因对心肌肌凝蛋白诱导的EAM具有较好的治疗作用。 Objective To study the amelioration of experimental autoimmune myocarditis (EAM) in BALB/c mice after immunosuppression by adenovirus-mediated gene transfer of antisense CⅡTA. Methods EAM mice with or without treatment of antisense CⅡTA gene mediated by adenovirus were sacrificed on day 21 after first immunization with myosin from porcine heart. Heart pathology grading, concentration of cTnⅠ, titer of auto-antibody and cell phenotype in spleen and peripheral blood were compared among various groups as CⅡTA therapy(CT), simple immune(SI), GFP control(GC) and normal control(NC). Results Pathological and serological evaluation showed significant amelioration of EAM in CT group as compared with SI and GC groups (P<0.05). There is no difference in I-Ad expression on CD3- cells, but the difference is significant on CD3+ cells derived from spleen and peripheral blood(P<0.05). Conclusion The antisense CⅡTA gene mediated by adenovirus can effectively suppress autoimmune response in vivo and ameliorate EAM induced by porcine heart myosin.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2005年第1期56-61,共6页 Chinese Journal of Microbiology and Immunology
基金 上海市科委联合利华基金资助项目 (2 0 0 2 0 5 )
关键词 CⅡTA 反义 基因 实验性自身免疫性 心肌肌凝蛋白 治疗 心肌炎 表达量 腺病毒载体 CⅡTA Antisense nuclear acid Adenovirus Gene therapy Experimental autoimmune myocarditis
  • 相关文献

参考文献10

  • 1Conant SB, Swanborg RH. Application of tetramer technology in studies on autoimmune diseases. Autoimmun Rev, 2003, 2(1): 43-49.
  • 2Chinen J, Shearer WT. Basic and clinical immunology. J Allergy Clin Immunol, 2003, 111(3 Suppl): S813-818.
  • 3Izumi T, Kohno K, Inomata T, et al. Myocantitogenic epitopes and autoimmune myocarditis, Intern Med, 2003, 42( 1 ) : 3-6.
  • 4Chang CHI Flavell RA. Class Ⅱ transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med, 1995, 181(2) : 765-767.
  • 5Hake SB, Tobin HM, Steimle V, et al. Comparison of the transcriptional regulation of classical and non-classical MHC class Ⅱ genes. Eur J Immunol, 2003, 33(9): 2361-2371.
  • 6Godsel LM, Wang K, Schodin BA, et al. Prevention of autoimmune myocarditis through the induction of antigen-specific peripheral immune tolerance. Circulation, 2001, 27, 103 (12): 1709-1714.
  • 7Murakami U, Uchida K, Hiratsuka T. Cardiac myosin from pig heart ventricle: purification and enzymatic properties. J Biochem(Tokyo),1976, 80(3): 611-619.
  • 8el-Khatib MR, Chason JL, Silberberg B, et al. Coxsachievirus B4 myocarditis in mice: valvular changes in virus-infected and control animals. J Infect Dis, 1978, 137: 410-420.
  • 9Kishimoto C, Shioji K, Kineshita M, et al. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress, Int J Cardiol, 2003, 91(2-3): 173-178.
  • 10Wierda WG, Cantwell MJ, Woods SJ, et al. CD40-ligand (CD154)gene therapy for chronic lymphocytic leukemia. Blood, 2000, 96 (9):2917-2924.

同被引文献21

  • 1Eriksson U, Bachmaier K, Penninger JM, et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity[J].Nat Med,2003,9(12):1 484-1 490.
  • 2Frustaci A, Cuoco L, Chimenti C, et al. Celiac disease associated with autoimmune myocarditis[J]. Circulation,2002,105(22) :2 611-2 618.
  • 3Frustaci A, Chimenti C, Calabrese F, et al. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders[J]. Circulation,2003,107(6) :857-863.
  • 4Bachmaier K, Neu N, Penninger JM,et al. Generation of humanized mice susceptible to peptide-induced inflammatory heart disease [J]. Circulation, 1999, 99(14):1 885-1 891.
  • 5Kohno K, Takagaki Y, Nakajima Y,et al. Advantage of recombinant technology for the identification of cardiac myosin epitope of severe autoimmune myocarditis in Lewis rats[J]. Jpn Heart J,2000,41(1) :67-77.
  • 6Kohno K, Takagaki Y, Aoyama N, et al. A peptide fragment of beta cardiac myosin heavy chain (beta-CMHC) can provoke autoimmune myocarditis as well as the corresponding alpha cardiac myosin heavy chain (alpha-CMHC) fragment [J]. Autoimmunity, 2001, 34(3) :177-185.
  • 7Galvin JE, Hemric ME, Kosanke SD,et al. Induction of myocarditis and valvulitis in lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis[J]. Am J Pathol, 2002,160 ( 1 ) : 297-306.
  • 8Li Y, Heuser JS, Kosanke SD,et al. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis Rat[J]. The Journal of Immunology,2004, 172(5): 3 225-3 234.
  • 9Nugent AW, Daubeney PE, Chondros P,et al. The epidemiology of childhood cardiomyopathy in Australia[J]. N Engl J Med,2003,348(17):l 639-1 646.
  • 10Suffredini AF. Current prospects for the treatment of clinical sepsis. Crit Care Med, 1994, 22(7): S12-18.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部